Alanna Angel
Family Medicine · Due West, SCNPI 1124005541
Payments from drug & device makers
Across 508 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$807
- Novo Nordisk$801
- AbbVie$771
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$761
- Lilly USA, LLC$654
- Novartis$401
- plus $4K from 47 others
What the payments were for
- Consulting fees$2253%
- Food & beverage$7,92097%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,145 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 108 | $142,436 |
| JardianceEmpagliflozin | 59 | $86,434 |
| EliquisApixaban | 41 | $53,135 |
| XifaxanRifaximin | 15 | $44,504 |
| TrulicityDulaglutide | 34 | $41,511 |
| BanzelRufinamide | 13 | $40,360 |
| OzempicSemaglutide | 25 | $38,482 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $29,257 |
| MyrbetriqMirabegron | 31 | $27,295 |
| JanuviaSitagliptin Phosphate | 16 | $26,591 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 16 | $25,669 |
| FarxigaDapagliflozin Propanediol | 14 | $22,215 |
| Diclofenac Sodium | 58 | $18,790 |
| XareltoRivaroxaban | 23 | $17,235 |
| Repatha SureclickEvolocumab | 17 | $15,907 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $654 | $183,946142 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $213 | $112,10375 claims |
| PfizerEliquis, Premarin | $353 | $56,79153 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $761 | $44,50415 claims |
| Eisai Inc.Banzel | $26 | $40,36013 claims |
| Novo NordiskOzempic | $801 | $38,48225 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $807 | $35,81830 claims |
| GSKTrelegy Ellipta | $370 | $29,25737 claims |
| Astellas Pharma US IncMyrbetriq | $33 | $27,29531 claims |
| MerckJanuvia | $30 | $26,59116 claims |
| Johnson & JohnsonXarelto | $48 | $17,23523 claims |
| IBSA Pharma Inc.Tirosint | $185 | $2,09511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Due West
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.